ArticleIndian journal of ophthalmology2021
Cilioretinal artery occlusion with paracentral acute middle maculopathy associated with COVID-19.
Article in Indian journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 29 citations in OpenAlex.
- Paracentral Acute Middle Maculopathy (PAMM) in Ocular Vascular Diseases-What We Know and Future Perspectives.Vision (Basel, Switzerland) · 2025Review
- [A blind spot while reading].Die Ophthalmologie · 2023Article
- The spectrum of COVID-19-associated chorioretinal vasculopathy.American journal of ophthalmology case reports · 2023Article
- Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023Review
- Retinal OCT findings in acute central retinal artery occlusion of varying severity at different disease stages - a retrospective, observational study.International journal of retina and vitreous · 2023Article
- Coincident Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy in COVID-19.Turkish journal of ophthalmology · 2023Article
- Different Cases, Different Manifestations of Post-COVID-19 Retinal Artery Occlusion: A Case Series.Turkish journal of ophthalmology · 2023Article
- Retinal tissue and microvasculature loss in COVID-19 infection.Scientific reports · 2023Article
- Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy during SARS-CoV-2 Infection and Vaccination.Vaccines · 2023Article
- Analysis of COVID-19 publications in theIndian journal of ophthalmology · 2022Article
- Paracentral acute middle maculopathy and COVID-19 vaccination: Causation versus coincidence finding.Clinical case reports · 2022Article
- MYTHS AND TRUTHS OF THE ASSOCIATION OF RETINAL VASCULAR OCCLUSION WITH COVID-19.Retina (Philadelphia, Pa.) · 2022Review
- Branch Retinal Artery Occlusions, Paracentral Acute Middle Maculopathy and Acute Macular Neuroretinopathy After COVID-19 Vaccinations.Clinical ophthalmology (Auckland, N.Z.) · 2022Article
- Comment on: Cilioretinal artery occlusion with paracentral acute middle maculopathy associated with COVID-19.Indian journal of ophthalmology · 2021Article
- Commentary: COVID-19 disease is more than just a respiratory infection.Indian journal of ophthalmology · 2021Article
- Paracentral acute middle maculopathy following COVID-19.Arquivos brasileiros de oftalmologiaArticle
- A Case of Branch Retinal Arteriole Occlusion and Paracentral Acute Middle Maculopathy after COVID-19 Infection.Case reports in ophthalmologyArticle
Corrections and comments
- Commented on by
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of the study is to describe cilioretinal artery (CILRA) occlusion that is presumed to be associated with COVID-19 without severe respiratory distress and inform ophthalmologists of unusual ocular presentations of COVID-19. Here, we present the first case of a patient with isolated CILRA occlusion and paracentral acute middle maculopathy (PAMM) after recently polymerase chain reaction-proven COVID-19. A 26-year-old female patient presented with a visual field defect in her left eye for 2 days and decreased vision compared to her right eye. It was learned that the patient had a laboratory-proven COVID-19 infection with mild respiratory symptoms that did not require hospitalization 2 weeks ago. Fundus examination revealed retinal edema in the left eye area supplied by the CILRA. Spectral-domain optical coherence tomography revealed a prominent hyperreflective band at the inner nuclear layer level. These findings led us to the diagnosis of isolated CILRA occlusion and PAMM associated with recent COVID-19. CILRA occlusion and PAMM could be associated with the inflammatory and procoagulant condition caused by the SARS-CoV-2 infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.